Intra Cellular Therapies reported $792.75M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 444.8M 96.1M
ALKERMES ALKS:US $ 1075.39M 37.19M
Aptinyx Inc APTX:US $ 77.48M 17.27M
Biocryst Pharmaceuticals BCRX:US $ -164.22M 57.23M
Biogen BIIB:US $ 11242.3M 346.1M
Bristol Myers Squibb BMY:US $ 31580M 4366M
Cytokinetics CYTK:US $ 116.26M 127.6M
Esperion Therapeutics ESPR:US $ -249040000 52.1M
Gilead Sciences GILD:US $ 19927M 1142M
Halozyme Therapeutics HALO:US $ 260.26M 63.3M
Intra Cellular Therapies ITCI:US $ 792.75M 374.86M
JAZZ PHA JAZZ:US $ 3608.49M 356.7M
Johnson & Johnson JNJ:US $ 74709M 686M
Marinus Pharmaceuticals MRNS:US $ 40.4M 13.08M
Minerva Neurosciences NERV:US $ -0.74M 8.71M
Nektar Therapeutics NKTR:US $ 607.89M 71.62M
Neurocrine Biosciences NBIX:US $ 1391.1M 17.1M
Novartis NVS:US $ 61540M 6115M
Prothena PRTA:US $ 438.89M 27.16M
Redhill Biopharma RDHL:US $ -5.24M 14.12M
Supernus Pharmaceuticals SUPN:US $ 828.45M 12.6M
United Therapeutics UTHR:US $ 4176.3M 217.4M
Vanda Pharmaceuticals VNDA:US $ 502.12M 2.8M